Particle Data Platform

SGLT2s For Long COVID

6:488:08 · 80s

Dr. Rose shares real-world success using SGLT2 inhibitors to reduce microclot burden and metabolic dysregulation in long COVID patients.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.